These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 33079062

  • 1. Do not forget megakaryocytes morphology when you deal with chronic myeloid leukaemia.
    Rieu JB, Tavitian S, Vergez F, Largeaud L.
    Ann Biol Clin (Paris); 2020 Dec 01; 78(6):691-692. PubMed ID: 33079062
    [No Abstract] [Full Text] [Related]

  • 2. Microplanimetric studies on megakaryocytes in chronic granulocytic leukaemia and polycythaemia vera.
    FRANZEN S, STRENGER G, ZAJICEK J.
    Acta Haematol; 1961 Dec 01; 26():182-93. PubMed ID: 13894731
    [No Abstract] [Full Text] [Related]

  • 3. Is it chronic idiopathic myelofibrosis, myelofibrosis with myeloid metaplasia, chronic megakaryocytic-granulocytic myelosis, or chronic megakaryocytic leukemia? Further thoughts on the nosology of the clonal myeloid disorders.
    Lichtman MA.
    Leukemia; 2005 Jul 01; 19(7):1139-41. PubMed ID: 15902283
    [No Abstract] [Full Text] [Related]

  • 4. Megakaryocytes carry the fused bcr-abl gene in chronic myeloid leukaemia: a fluorescence in situ hybridization analysis from bone marrow biopsies.
    Nolte M, Werner M, Ewig M, von Wasielewski R, Link H, Diedrich H, Georgii A.
    Virchows Arch; 1996 Mar 01; 427(6):561-5. PubMed ID: 8605566
    [Abstract] [Full Text] [Related]

  • 5. Can morphological assessment limit the use of specific genetic testing to exclude chronic myeloid leukaemia?
    So CC, Wan TS, Yip SF, Ma SK, Lam CC, Chan LC.
    Br J Haematol; 2007 May 01; 137(4):377. PubMed ID: 17374140
    [No Abstract] [Full Text] [Related]

  • 6. CD34-positive dwarf megakaryocytes in chronic myeloid leukemia are not indicators of disease progression.
    Bhuyan B, Padhi S.
    Indian J Pathol Microbiol; 2023 May 01; 66(2):421-422. PubMed ID: 37077103
    [No Abstract] [Full Text] [Related]

  • 7. Another set of guidelines for chronic myeloid leukaemia.
    Clark RE.
    Br J Haematol; 2020 Oct 01; 191(2):147-149. PubMed ID: 32712951
    [No Abstract] [Full Text] [Related]

  • 8. Philadelphia chromosome and/or bcr-abl mRNA-positive primary thrombocytosis: morphometric evidence for the transition from essential thrombocythaemia to chronic myeloid leukaemia type of myeloproliferation.
    Pajor L, Kereskai L, Zsdrál K, Nagy Z, Vass JA, Jáksó P, Radványi G.
    Histopathology; 2003 Jan 01; 42(1):53-60. PubMed ID: 12493025
    [Abstract] [Full Text] [Related]

  • 9. Concomitant diagnosis of chronic myeloid leukaemia and myeloma.
    Looi W, Zargari A, Dun K, Grigoriadis G, Fedele P, Gregory GP, Low MSY.
    Pathology; 2022 Jun 01; 54(4):493-495. PubMed ID: 34776244
    [No Abstract] [Full Text] [Related]

  • 10. Clinical and cytogenetic correlations of abnormal megakaryocytopoiesis in patients with acute leukemia and chronic myelogenous leukemia in blast crisis.
    Lee EJ, Schiffer CA, Tomiyasu T, Testa JR.
    Leukemia; 1990 May 01; 4(5):350-3. PubMed ID: 2388480
    [Abstract] [Full Text] [Related]

  • 11. Chronic myeloid leukaemia. I. Some observations on chronic myeloid leukaemia.
    GALTON DA.
    Br J Radiol; 1953 Jun 01; 26(306):285-90. PubMed ID: 13051542
    [No Abstract] [Full Text] [Related]

  • 12. Histamine and histaminase in chronic myeloid leukaemia of man: histamine in the blood of chronic myeloid leukaemia.
    THIERSCH JB.
    Aust J Exp Biol Med Sci; 1947 Mar 01; 25():73-7. PubMed ID: 20266429
    [No Abstract] [Full Text] [Related]

  • 13. Specific Features of Interactions between Megakaryocytic and Granulocytic Hematopoiesis Lineages and Myelofibrosis during the Acute Phase of Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia, and Multiple Myeloma.
    Dolgikh TY, Senchukova SR, Vinogradova EV, Krinitsyna YM.
    Bull Exp Biol Med; 2020 Apr 01; 168(6):734-738. PubMed ID: 32333309
    [Abstract] [Full Text] [Related]

  • 14. Fluorescence in-situ hybridization (FISH) reveals that in chronic myelogenous leukaemia (CML) following interferon-alpha therapy, normalization of megakaryocyte size is associated with the loss of bcr/abl translocation.
    Thiele J, Schmitz B, Gross H, Kvasnicka HM, Niederle N, Leder LD, Fischer R.
    Histopathology; 1997 Sep 01; 31(3):215-21. PubMed ID: 9354890
    [Abstract] [Full Text] [Related]

  • 15. Megakaryocyte features and bcr/abl translocation in chronic myeloid leukemia following imatinib mesylate (STI571) therapy--a fluorescence in-situ hybridization study.
    Thiele J, Kvasnicka HM, Varus E, Ollig E, Schmitt-Graeff A, Staib P, Griesshammer M.
    Leuk Lymphoma; 2004 Aug 01; 45(8):1627-31. PubMed ID: 15370216
    [Abstract] [Full Text] [Related]

  • 16. Chronic myeloid leukaemia in megakaryocytic crisis.
    Ranjitkumar S, Lindeman R.
    Br J Haematol; 2002 Jun 01; 117(3):487. PubMed ID: 12028013
    [No Abstract] [Full Text] [Related]

  • 17. Chemotherapy of leukaemia. I. Myleran in the treatment of chronic myeloid leukaemia.
    GREIG HB.
    S Afr Med J; 1956 Apr 14; 30(15):357-60. PubMed ID: 13324391
    [No Abstract] [Full Text] [Related]

  • 18. Managing children with chronic myeloid leukaemia.
    Baccarani M.
    Br J Haematol; 2015 Jun 14; 169(5):759-60. PubMed ID: 25430625
    [No Abstract] [Full Text] [Related]

  • 19. Evaluation of two CE-IVD tests for BCR-ABL1 transcript monitoring of chronic myeloid leukemia patients.
    Folta A, Jurcek T, Kubesova B, Zackova D, Semerad L, Mayer J, Jeziskova I.
    Leuk Lymphoma; 2021 May 14; 62(5):1239-1242. PubMed ID: 33356699
    [No Abstract] [Full Text] [Related]

  • 20. Chronic myeloid leukaemia.
    PINEY A.
    Br J Clin Pract; 1956 Oct 14; 10(10):643; passim. PubMed ID: 13374173
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.